InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
Last trade$14.92
Day change+$0.13 (+0.88%)
Day range$14.60 – $14.94
Volume46,729
Market cap$296M
OpenXASE
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$296.3M
Price / earnings
31.39×
Price / book
4.62×
Price / sales
2.05×
EV / sales
2.12×
EV / EBITDA
11.32×
Profitability
Earnings per share
$0.47
Return on assets
9.03%
Return on equity
14.72%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0.31×
Current ratio
2.68×
Quick ratio
2.39×
Cash ratio
0.51×
Cash flow
Price / cash flow
11.75×
Price / free cash flow
22.33×
Free cash flow
$13.27M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for INFU, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$37.59M
$36.93M
$33.68M
$36.23M
$36.49M
$36M
$34.72M
$33.85M
Cost of revenue
$15.86M
$15.52M
$14M
$15.8M
$15.67M
$16.13M
$15.55M
$15.63M
Gross profit
$21.73M
$21.41M
$19.68M
$20.44M
$20.82M
$19.87M
$19.17M
$18.22M
Selling, general and administrative
$16.82M
$17.09M
$17.88M
$16.51M
$16.8M
$15.85M
$18.3M
$15.35M
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$16.98M
$17.26M
$18.09M
$16.72M
$17.01M
$16.1M
$18.55M
$15.6M
Operating income
$4.75M
$4.15M
$1.59M
$3.71M
$3.81M
$3.78M
$618K
$2.62M
Interest expense
-$257K
-$255K
-$255K
-$260K
-$330K
-$373K
-$336K
-$361K
Income before taxes
$4.54M
$3.87M
$1.42M
$3.5M
$3.43M
$3.45M
$253K
$2.26M
Income taxes
$1.39M
$640K
$400K
$1.46M
$1.17M
$847K
$520K
$1.33M
Net income
$3.16M
$3.23M
$1.02M
$2.04M
$2.26M
$2.6M
-$267K
$933K
Net income attributable to common shareholders
$3.16M
$3.23M
$1.02M
$2.04M
$2.26M
$2.6M
-$267K
$933K
EBITDA
$7.87M
$7.33M
$4.84M
$7.06M
$7.1M
$7.12M
$3.94M
$6.04M
Basic earnings per share
$0.16
$0.16
$0.05
$0.10
$0.11
$0.12
-$0.01
$0.04
Diluted earnings per share
$0.15
$0.15
$0.05
$0.10
$0.11
$0.12
-$0.01
$0.04
Recent news
Company coverage with links to the original publishers.
InfuSystem reported strong Q2 2025 earnings with EPS of $0.12, exceeding analyst expectations. Revenue grew 6.8% to $36.0 million, with operational improvements in Device Solutions and oncology segments, though revenue growth guidance was tempered.
The global wound cleanser product market is estimated to reach $2.24 billion by 2034, driven by the growing elderly population, traumatic injuries, surgical procedures, and obesity/diabetes leading to an increase in acute, chronic, and surgical wounds. Technological advancements in wound cleanser formulations have also contributed to market growth.
Gainers
ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share in cash.
Onion Global Limited (NYSE: OG) jumped 90.6% to close at $0.7624 on Thursday.
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares surged 81% to close at $8.00 on Thursday after gaining over 12% on Wednesday.
Minerva Neurosciences, Inc. (NASDAQ: NERV) gained 75.4% to close at $4.70.
Missfresh Limited (NASDAQ: MF) shares climbed 51.7% to close at $0.1746 after dropping 7% on Wednesday.
NanoViricides, Inc. (NYSE: NNVC) climbed 48.4% to close at $3.65 after the company announced it has begun drug development to combat Monkeypox virus.
ZW Data Action Technologies Inc. (NASDAQ: CNET) jumped 44.4% to close at $0.83. ZW Data Action Technologies recently collaborated with Forbes Global Alliance to build the Forbes China Group Digital Collection Platform to launch NFT Products and jointly operate the platform data.
Yellow Corporation (NASDAQ: YELL) rose 42.2% to close at $6.70 after the company swung to a profit for the second quarter.
Global Blood Therapeutics, Inc. (NASDAQ: GBT) gained 41.4% to close at $47.99 following a report suggesting the company is attracting takeover interest. According to a Bloomberg report, citing people familiar with the matter, some large pharmaceutical companies are looking into a potential deal.
Applied DNA Sciences, Inc. (NASDAQ: APDN) climbed 40% to settle at $5.74 as the company reported pricing of $12 million upsized offering.
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares jumped 38.1% to settle at $0.1560 after gaining around 9% on Wednesday.
Greenpro Capital Corp. (NASDAQ: GRNQ) gained 37.7% to close at $2.41 after climbing around 14% on Tuesday after climbing 28% on Wednesday.
Quhuo Limited (NASDAQ: QH) rose 37.6% to close at $0.45.
Forge Global Holdings, Inc. (NYSE: FRGE) jumped 33% to close at $6.05. Forge Global is expected to report Q2 financial results on August 11, 2022.
Legacy Housing Corporation (NASDAQ: LEGH) jumped 30.4% to close at $17.62 after the company late Wednesday re-stated Q1, Q2 and Q3 interim financial statements for FY21.
GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 30.3% to close at $3.57. Geovax Labs posted a Q2 loss of $0.21 per share.
GreenLight Biosciences Holdings (NASDAQ: GRNA) shares rose 27.6% to close at $4.16 after jumping over 25% on Wednesday. Samsung Biologics and the company recently announced the completion of the first commercial-scale engineering run for the companies' mRNA production partnership.
Waitr Holdings Inc. (NASDAQ: WTRH) jumped 26.9% to settle at $0.4288.
Society Pass Incorporated (NASDAQ: SOPA) jumped 26.2% to close at $2.36 after reporting 2Q 2022 and 1H 2022 financial results.
Exicure, Inc. (NASDAQ: XCUR) shares gained 25.6% to close at $2.50 after climbing around 27% on Wednesday.
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 23.2% to close at $13.74 after the company reported better-than-expected Q2 EPS and sales results. The company also announced the FDA has lifted its partial clinical hold on the BCX9930 program.
Immunic, Inc. (NASDAQ: IMUX) gained 23.1% to close at $4.79 following Q2 results.
PagSeguro Digital Ltd. (NYSE: PAGS) gained 22.9% to close at $15.03.
TTM Technologies, Inc. (NASDAQ: TTMI) rose 22.4% to close at $16.53 following upbeat Q2 results.
Altice USA, Inc. (NYSE: ATUS) surged 21.5% to close at $11.75 following strong quarterly sales.
Amesite Inc. (NASDAQ: AMST) gained 20.9% to close at $0.52.
Pintec Technology Holdings Limited (NASDAQ: PT) jumped 18.5% to close at $1.2201.
Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) jumped 18.8% to close at $0.2642.
Precigen, Inc. (NASDAQ: PGEN) jumped 18.4% to settle at $2.12.
Digital Brands Group, Inc. (NASDAQ: DBGI) rose 16.7% to close at $0.14. Digital Brands Group, last month, received a determination letter from the Nasdaq stating that the Company has not regained compliance.
MercadoLibre, Inc. (NASDAQ: MELI) rose 16.2% to close at $1,034.83 following better-than-expected quarterly ...
Gainers
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.
Onion Global Limited (NYSE: OG) gained 113.9% to $0.8556.
ChemoCentryx, Inc. (NASDAQ: CCXI) gained 110% to $50.68 after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share in cash.
Minerva Neurosciences, Inc. (NASDAQ: NERV) jumped 80% to $4.8300.
Greenpro Capital Corp. (NASDAQ: GRNQ) rose 61.1% to $2.82 after climbing around 14% on Tuesday after climbing 28% on Wednesday.
Missfresh Limited (NASDAQ: MF) shares surged 59.3% to $0.1834 after dropping 7% on Wednesday.
Quhuo Limited (NASDAQ: QH) gained 51.8% to $0.4966.
Yellow Corporation (NASDAQ: YELL) rose 44.1% to $6.79 after the company swung to a profit for the second quarter.
Society Pass Incorporated (NASDAQ: SOPA) gained 42.8% to $2.6700 after reporting 2Q 2022 and 1H 2022 financial results.
GreenLight Biosciences Holdings (NASDAQ: GRNA) shares gained 39.6% to $4.55 after jumping over 25% on Wednesday. Samsung Biologics and the company recently announced the completion of the first commercial-scale engineering run for the companies' mRNA production partnership.
ZW Data Action Technologies Inc. (NASDAQ: CNET) surged 37.5% to $0.79. ZW Data Action Technologies recently collaborated with Forbes Global Alliance to build the Forbes China Group Digital Collection Platform to launch NFT Products and jointly operate the platform data.
Global Blood Therapeutics, Inc. (NASDAQ: GBT) rose 36.5% to $46.31 following a report suggesting the company is attracting takeover interest. According to a Bloomberg report, citing people familiar with the matter, some large pharmaceutical companies are looking into a potential deal.
Legacy Housing Corporation (NASDAQ: LEGH) rose 29.9% to $17.55. Legacy Housing will restate its 1st, 2nd, 3rd quarters unaudited interim financial statements for FY21, Reuters reported.
Forge Global Holdings, Inc. (NYSE: FRGE) jumped 27.8% to $5.82. Forge Global is expected to report Q2 financial results on August 11, 2022.
Molecular Data Inc. (NASDAQ: MKD) gained 26.3% to $0.7701.
Waitr Holdings Inc. (NASDAQ: WTRH) surged 26% to $0.4267.
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) gained 25.5% to $14.00 after the company reported better-than-expected Q2 EPS and sales results. The company also announced the FDA has lifted its partial clinical hold on the BCX9930 program.
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares rose 25.5% to $0.1418 after gaining around 9% on Wednesday.
Immunic, Inc. (NASDAQ: IMUX) gained 25% to $4.89 following Q2 results.
NanoViricides, Inc. (NYSE: NNVC) jumped 23.5% to $3.04 after the company announced it has begun drug development to combat Monkeypox virus.
Exela Technologies, Inc. (NASDAQ: XELA) rose 20.5% to $1.7594 after the company announced an update on its capital deployment strategy. Exela Technologies says the company has purchased $70 million of face value 2026 Senior Secured Notes at a discount with funds raised from equity. This will be the first contribution to the company's STS ("Serve the Shareholders") initiative.
Ashford Inc. (NYSE: AINC) gained 20.1% to $16.78 following Q2 earnings.
Staffing 360 Solutions, Inc. (NASDAQ: STAF) surged 20% to $3.8462.
Synthetic Biologics, Inc. (NYSE: SYN) rose 19.4% to $1.77. Synthetic Biologics recently announced a $3 million private placement of convertible preferred stock.
Eloxx Pharmaceuticals, Inc. (NASDAQ:
InfuSystems Holdings, Inc. (INFU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.